Chen Lv

564 total citations
24 papers, 430 citations indexed

About

Chen Lv is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chen Lv has authored 24 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Chen Lv's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Chen Lv is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Chen Lv collaborates with scholars based in China. Chen Lv's co-authors include Guanjun Tu, Zhengxiang Huang, Yaxin Han, Yao Shi, Shengwu Yang, Wenjun Lin, Yi Chen, Shi Li, Jinfeng Zhou and Xiao Ni and has published in prestigious journals such as Advanced Functional Materials, Biochemical and Biophysical Research Communications and Frontiers in Pharmacology.

In The Last Decade

Chen Lv

24 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Lv China 14 266 187 44 43 34 24 430
Andreas R. Baudy United States 10 343 1.3× 135 0.7× 33 0.8× 90 2.1× 39 1.1× 12 528
Xiaojun Huang China 10 292 1.1× 108 0.6× 16 0.4× 58 1.3× 37 1.1× 14 443
Danni Deng China 13 493 1.9× 400 2.1× 41 0.9× 45 1.0× 19 0.6× 24 642
Yunxia Ma China 14 402 1.5× 213 1.1× 28 0.6× 102 2.4× 19 0.6× 41 626
Xiaoying Zhang China 12 321 1.2× 181 1.0× 40 0.9× 56 1.3× 30 0.9× 38 517
Tatiana Favez Switzerland 8 377 1.4× 62 0.3× 29 0.7× 50 1.2× 44 1.3× 16 495
Mingbo Cao China 7 205 0.8× 104 0.6× 17 0.4× 140 3.3× 30 0.9× 14 430
Lu Kong China 12 292 1.1× 87 0.5× 30 0.7× 70 1.6× 20 0.6× 33 462
Nicole J. Croteau United States 6 300 1.1× 230 1.2× 29 0.7× 30 0.7× 36 1.1× 6 495

Countries citing papers authored by Chen Lv

Since Specialization
Citations

This map shows the geographic impact of Chen Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Lv more than expected).

Fields of papers citing papers by Chen Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Lv. The network helps show where Chen Lv may publish in the future.

Co-authorship network of co-authors of Chen Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Lv. A scholar is included among the top collaborators of Chen Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Lv. Chen Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fei, Fan, Liang Peng, Xuejun Zhao, et al.. (2024). Unconventional Fluorescent Magnetic Mesoporous Microspheres for Visualizing Latent Fingerprints. Advanced Functional Materials. 35(13). 4 indexed citations
3.
Cui, Wenxing, et al.. (2024). Novel targets and therapies of metformin in dementia: old drug, new insights. Frontiers in Pharmacology. 15. 1415740–1415740. 7 indexed citations
4.
Yang, Qin, Jiayi Jin, Jiani Zhang, et al.. (2023). A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis. Biomedicine & Pharmacotherapy. 168. 115666–115666. 6 indexed citations
5.
Wang, Lu, Wei Su, Wenjun Lin, et al.. (2023). BML‐111 inhibits osteoclast differentiation by suppressing the MAPK and NF‐κB pathways, alleviating deterioration of the knee joints in a CIA rat model. Cell Biology International. 47(5). 954–968. 3 indexed citations
6.
Li, Yunxiang, et al.. (2023). LncRNA TYMSOS is a novel prognostic biomarker associated with immune infiltration in prostate cancer.. PubMed. 13(10). 4531–4546. 1 indexed citations
7.
Su, Wei, et al.. (2022). Glucosamine delays the progression of osteoporosis in senile mice by promoting osteoblast autophagy. Nutrition & Metabolism. 19(1). 75–75. 7 indexed citations
8.
Su, Wei, et al.. (2022). Glucosamine suppresses oxidative stress and induces protective autophagy in osteoblasts by blocking the ROS/Akt/mTOR signaling pathway. Cell Biology International. 46(5). 829–839. 12 indexed citations
9.
Huang, Zhengxiang, et al.. (2021). Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2. Journal of Chemotherapy. 33(5). 328–341. 8 indexed citations
10.
Lv, Chen, Siyuan Sun, Heping Zhao, et al.. (2021). TSP1 is the essential domain of SEMA5A involved in pannus formation in rheumatoid arthritis. Lara D. Veeken. 60(12). 5833–5842. 14 indexed citations
11.
Zhou, Jinfeng, Zhengxiang Huang, Xiao Ni, & Chen Lv. (2020). Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway. Toxicology in Vitro. 65. 104775–104775. 25 indexed citations
12.
Lv, Chen, Lu Wang, Wenjun Lin, et al.. (2018). Glucosamine promotes osteoblast proliferation by modulating autophagy via the mammalian target of rapamycin pathway. Biomedicine & Pharmacotherapy. 99. 271–277. 28 indexed citations
13.
Chen, Xin, Chen Lv, Wenjun Lin, et al.. (2018). MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53. Oncology Letters. 17(2). 1664–1674. 23 indexed citations
14.
Lin, Wenjun, Shengwu Yang, Xin Chen, et al.. (2017). MicroRNA-203 inhibits proliferation and invasion, and promotes apoptosis of osteosarcoma cells by targeting Runt-related transcription factor 2. Biomedicine & Pharmacotherapy. 91. 1075–1084. 24 indexed citations
15.
Lv, Chen, Shengwu Yang, Xin Chen, et al.. (2017). MicroRNA-21 promotes bone mesenchymal stem cells migration in vitro by activating PI3K/Akt/MMPs pathway. Journal of Clinical Neuroscience. 46. 156–162. 22 indexed citations
16.
Lv, Chen, et al.. (2016). MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway. Tumor Biology. 37(7). 9333–9342. 47 indexed citations
17.
Lv, Chen, Yaxin Han, Wei Zhang, et al.. (2016). Role and mechanism of microRNA-21 in H2O2-induced apoptosis in bone marrow mesenchymal stem cells. Journal of Clinical Neuroscience. 27. 154–160. 24 indexed citations
18.
Shi, Yao, Yiwen Hu, Chen Lv, & Guanjun Tu. (2016). Effects of Reactive Oxygen Species on Differentiation of Bone Marrow Mesenchymal Stem Cells. Annals of Transplantation. 21. 695–700. 22 indexed citations
19.
Tu, Guanjun, et al.. (2014). Matrix metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via PI3K/Akt pathway and is involved in CCL19-driven BMSCs migration. Biochemical and Biophysical Research Communications. 451(2). 222–228. 24 indexed citations
20.
Tu, Guanjun, et al.. (2014). Overexpression of microRNA-124 promotes the neuronal differentiation of bone marrow-derived mesenchymal stem cells. Neural Regeneration Research. 9(12). 1241–1241. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026